At an unbeatable cost price, CellRx Short AE-IGF-1 offers maximum performance at the best value for both small and large volume consumers
LONG R3 IGF-1
- Leading Suppliers
- Leading Suppliers
CellRx Short AE-IGF-1 price comparison is shown against published catalogue rates for 500mg of LONG R3 IGF-1 and 50g of Insulin.
(Reference insulin potency taken as 1/100th of IGF-1)
For larger (bulk) volumes Short AE-IGF-1 offers at least 2-3x better value than the competing products.
Commercial-grade growth factor designed for scale
Regulatory compliant, GMP and 100% animal-free
Short AE-IGF-1 is manufactured in a proprietary E. coli fermentation process under ISO 13485 conditions, conforms to all FDA QSR guidelines, is certified 100% animal free to a tertiary level and has requisite CofA’s. The manufacturing plant is audited by major US, European and Japanese biopharmaceutical companies.
A certificate of origin is available on request.
Comprehensive risk management and supply security
Short AE-IGF-1 inventory is built in advance to handle the fluctuating needs of customers and is available for immediate shipment. A comprehensive risk management strategy includes an inventory surplus equal to 2 year’s forecast demand and is maintained in secured storage facilities at relevant sites. For a complete overview of the risk management strategy, please contact your CellRx sales representative.
Broad use across cell lines
Short AE-IGF-1 has been used with numerous cell types including CHO, vaccine-producing cell lines, fibroblasts and stem cells. All cells that have a functional Type 1 IGF receptor will respond to Short AE-IGF-1. This includes commercially available Cell lines such as CHO, PER.C6, BHK, HEK 293, Embryonic stem cells, mesenchymal stem cells, hematopoietic stem cells, fibroblasts, and hybridomas.
User-friendly formulations for greater flexibility
Short AE-IGF-1 is supplied as a stable soluble product that can be added directly into cell culture media without any further handling or risk of influence on cell culture pH and osmolality. Liquid, Short AE-IGF-1, in original unopened vial is stable for at least 4 years when stored at 2-8°C.
Produced under strict FDA, EMA and GMP quality guidelines
CellRx Short AE-IGF-1 is available for immediate world-wide shipping.
Please use the order request form below to initiate your order or contact us for any questions or purchase enquiries
|Price (US $)
*Contact us for bulk pricing options and evaluation samples.
Store at 2-8°C
Storage and handling of the product should be maintained between 2-8°C for optimum stability and efficacy.
Here to help!
Do give us a call or email us for more information about the product and purchase enquiries.
Tel: + 44 1223 364 412
CellRx Limited (CellRx) is a manufacturer and supplier of growth factors that serve the technical research and bioprocessing markets. Our first product to market is Short AE-IGF-1, a well-characterized, high potency, competitively priced alternative to insulin and other insulin-like analogues. CellRx also offers a range of services to the bioprocessing industry including GMP contract manufacturing, bioprocess development and optimization.
CellRx Short AE-IGF-1 is available for laboratory research and large-scale in-vitro biopharmaceutical manufacturing use only. Not for diagnostic or therapeutic use.
Short™ AE-IGF-1 is a registered trademark of CellRx Ltd. (Synonyms include AE-IGF-1, RhShort AE-IGF-1, Short IGF). LONG® is a registered trademark of Novozymes Biopharma AU.